On January 30, 2024, Aqemia SAS closed the transaction. The company has received ?30 million in its second and final tranche closing led by new investor Wendel Growth and received a total of ?60 million in the transaction. The company issued common shares in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
84.95 EUR | +3.16% | +4.88% | +18.23% |
Apr. 24 | Tikehau Capital: 13% increase in assets under management in Q1 | CF |
Apr. 22 | Eurazeo: agreement to invest in Eres Group | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.23% | 6.68B | |
-6.03% | 113B | |
-3.98% | 87.91B | |
+20.42% | 63.85B | |
+5.29% | 61.9B | |
+10.12% | 42.86B | |
+7.95% | 40.84B | |
+18.92% | 34.58B | |
+5.88% | 25.46B | |
-5.25% | 22.13B |
- Stock Market
- Equities
- RF Stock
- News Eurazeo SE
- Aqemia SAS announced that it has received ?60 million in funding from Bpifrance Investissement SAS, Eurazeo SE, Elaia Partners, Wendel Growth